Genvax Technologies
Latest round
- Seed
Last raised
- Feb 2025
Total raised
- $13M
Investors
- 7
About Genvax Technologies
Founded in 2021 and based in Iowa, US, Genvax Technologies, Inc. operates as a biotechnology company that enagges in the development of vaccines for animal disease prevention and treatment. In February 2025, Genvax Technologies, Inc. Genvax Technologies specializes in the development of mRNA and nanoparticle vaccines aimed at the prevention and treatment of animal diseases. Their core product offerings focus on enhancing vaccine efficacy through precise gene integration, which is essential for addressing specific health challenges in livestock. By leveraging advanced biotechnology, Genvax seeks to improve animal health outcomes, thereby benefiting farmers and the agricultural industry as a whole. The company primarily serves livestock producers and veterinarians in the United States and select international markets, focusing on regions with significant livestock populations. These vaccines are designed to ensure the health and productivity of animals, addressing critical end use cases such as disease prevention in cattle, poultry, and swine. Genvax Technologies operates on a B2B model, engaging directly with livestock producers and veterinary clinics to supply its vaccine products. The company’s revenue structure includes sales of individual vaccine doses or bulk supply agreements tailored to the needs of agricultural clients. The company is also focused on designing and launching new vaccine products targeting specific diseases in livestock, with plans to expand its reach into new markets, particularly regions with high livestock concentrations, by mid-2025.
Who invested in Genvax Technologies
7 investors across 3 rounds
See all investors in Genvax Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Genvax Technologies
Who invested in Genvax Technologies?
Genvax Technologies has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Genvax Technologies raised?
Genvax Technologies has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Genvax Technologies last raise money?
Genvax Technologies's most recent round on record is a Seed, in Feb 2025.
What does Genvax Technologies do?
Founded in 2021 and based in Iowa, US, Genvax Technologies, Inc.
Where is Genvax Technologies headquartered?
Genvax Technologies is headquartered in Ames, US.
Which VCs invest in companies like Genvax Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Genvax Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Genvax Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.